The in- or exclusion of non-breast cancer related death and contralateral breast cancer significantly affects estimated outcome probability in early breast cancer.
about
Challenges in translating endpoints from trials to observational cohort studies in oncologyMaastricht Delphi consensus on event definitions for classification of recurrence in breast cancer researchGuidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.Acute lymphoblastic leukemia in elderly patients: a single institution's experience.Inconsistent selection and definition of local and regional endpoints in breast cancer research.Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project†.Time-to-event endpoints in operable non-small-cell lung cancer randomized clinical trials.A Comprehensive Multistate Model Analyzing Associations of Various Risk Factors With the Course of Breast Cancer in a Population-Based Cohort of Breast Cancer Cases.Patterns and predictors of first and subsequent recurrence in women with early breast cancer.P-cadherin expression as a prognostic biomarker in a 3992 case tissue microarray series of breast cancer.
P2860
Q26746190-3673AD7A-B1AF-4B99-80AD-B87220524C4AQ26995439-3D90578C-35E8-45E3-9F1C-04FA7D989AD7Q27027579-1F9C4E55-3583-4DA3-B0B1-993FE79D5FAFQ35214578-5A1E63C9-6D83-485E-A053-634674B08DF3Q35331684-EF94E998-E667-4917-A5E4-8BECB8FD149EQ38259456-7F4B5110-C209-44BF-A1C6-FED3BAA1DACDQ38586999-6085A537-13D5-4E7D-8DC2-BDE88E8ADBE8Q39034554-EBBB6D63-C983-4363-B32A-C88A4360CF3FQ40943174-72A356B3-2F1C-4689-8ED4-E6EFA212FE8FQ42359892-6EE887A6-57BE-4661-A32D-DB72DAA5FD09Q42477262-6185F428-C9E7-4A7B-9C17-018D5FB052A6
P2860
The in- or exclusion of non-breast cancer related death and contralateral breast cancer significantly affects estimated outcome probability in early breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 July 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The in- or exclusion of non-br ...... bility in early breast cancer.
@en
The in- or exclusion of non-br ...... bility in early breast cancer.
@nl
type
label
The in- or exclusion of non-br ...... bility in early breast cancer.
@en
The in- or exclusion of non-br ...... bility in early breast cancer.
@nl
prefLabel
The in- or exclusion of non-br ...... bility in early breast cancer.
@en
The in- or exclusion of non-br ...... bility in early breast cancer.
@nl
P2093
P2860
P1476
The in- or exclusion of non-br ...... bility in early breast cancer.
@en
P2093
P2860
P2888
P304
P356
10.1007/S10549-007-9681-X
P407
P577
2007-07-28T00:00:00Z